What's new in atopic eczema? An analysis of systematic reviews published in 2017. Part 1: treatment and prevention.

Abstract

This review forms part of a series of annual updates that summarize the evidence base for atopic eczema (AE). It provides a summary of key findings from 25 systematic reviews that were published or indexed during 2017, and focuses on the treatment and prevention of AE. There is high-quality evidence to demonstrate that dupilumab is better than placebo for the treatment of AE, is not associated with a higher incidence of adverse effects and does not increase the risk of infection compared with placebo; however, comparison studies with other systemic treatments are necessary. Topical tofacitinib is a promising treatment for mild-moderate AE, but currently lacks sufficient evidence from well-designed randomized controlled trials (RCTs) comparing with other active treatments. Topical doxepin may be effective for pruritus in AE, but available studies have short follow-up periods and longer-term outcomes are needed. Bleach baths were no more effective than water baths alone at reducing AE severity. Topical antibiotics cannot be recommended for infected AE, owing to insufficient evidence of benefit. There is little comparison of different emollients in RCTs, but overall evidence indicates that they reduce AE severity, are steroid-sparing and lead to better outcomes in combination with topical corticosteroids (TCS) than TCS alone. No clear benefit was demonstrated for vitamin D/C/E supplementation in pregnancy for eczema prevention.

• Authors: A G H Wernham, D Veitch, D J C Grindlay, N K Rogers, K E Harman
• Journal: Clinical and experimental dermatology (Clin Exp Dermatol) Vol. 44 Issue 8 Pg. 861-867 (Dec 2019) ISSN: 1365-2230 [Electronic] England
• PMID: 31392785 (Publication Type: Journal Article, Review)
• Copyright: © 2019 British Association of Dermatologists.

Chemical References

• Antibodies, Monoclonal, Humanized
• Dermatologic Agents
• Emollients
• Vitamins
• dupilumab

Topics

• Antibodies, Monoclonal, Humanized (therapeutic use)
• Complementary Therapies
• Dermatitis, Atopic (diet therapy, drug therapy, prevention & control, psychology)
• Dermatologic Agents (therapeutic use)
• Emollients
• Female
• Humans
• Pregnancy
• Systematic Reviews as Topic
• Vitamins (therapeutic use)